The Institute of Environmental Sciences and Technology (IEST) recently published the High-Intensity Acoustics Testing Recommended Practice (RP), IEST-RP-DTE040.1. Developed by IEST Working Group ...
With a few tweaks to the protocol, Rocket Pharmaceuticals Inc.’s phase II trial testing RP-A501 in Danon disease is expected to resume following the lifting of the clinical hold, issued by the U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results